{"pmid":32452670,"title":"Immunity-Boosting Spices and the Novel Coronavirus.","text":["Immunity-Boosting Spices and the Novel Coronavirus.","Although there is no reported genetic predisposition in contracting coronavirus disease 2019 (COVID-19), the mortality rate varies among different ethnic groups. Here we determined potential correlation between COVID-19 and spice consumption. The data from 163 countries including total cases, total deaths, and total recovered were analyzed. It was observed that there is a clear interrelated prevalence between the total number of COVID-19 cases per million population tested and the gram of spice supply per capita per day. Nations with lower consumptions of spices per capita showed greater number of COVID-19 cases per million population. This is not surprising as herbs and spices are well-known to boost immunity. Although the precise molecular mechanisms associated with spices and immunity are not completely understood, our findings led us to hypothesize that spice consumption plays a role in our ability to fight COVID-19; however, intensive research is needed to determine the translational value of these findings.","ACS Chem Neurosci","Elsayed, Yehya","Khan, Naveed Ahmed","32452670"],"abstract":["Although there is no reported genetic predisposition in contracting coronavirus disease 2019 (COVID-19), the mortality rate varies among different ethnic groups. Here we determined potential correlation between COVID-19 and spice consumption. The data from 163 countries including total cases, total deaths, and total recovered were analyzed. It was observed that there is a clear interrelated prevalence between the total number of COVID-19 cases per million population tested and the gram of spice supply per capita per day. Nations with lower consumptions of spices per capita showed greater number of COVID-19 cases per million population. This is not surprising as herbs and spices are well-known to boost immunity. Although the precise molecular mechanisms associated with spices and immunity are not completely understood, our findings led us to hypothesize that spice consumption plays a role in our ability to fight COVID-19; however, intensive research is needed to determine the translational value of these findings."],"journal":"ACS Chem Neurosci","authors":["Elsayed, Yehya","Khan, Naveed Ahmed"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452670","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1021/acschemneuro.0c00239","keywords":["covid-19","coronavirus","immunity","spices"],"topics":["Mechanism"],"weight":1,"_version_":1667983494594166784,"score":9.490897,"similar":[{"pmid":32362243,"title":"Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.","text":["Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.","The 2019-novel coronavirus (nCoV) has caused a global health crisis by causing coronavirus disease-19 (COVID-19) pandemic in the human population. The unavailability of specific vaccines and anti-viral drug for nCoV, science demands sincere efforts in the field of drug design and discovery for COVID-19. The novel coronavirus main protease (SARS-CoV-2 Mpro) play a crucial role during the disease propagation, and hence SARS-CoV-2 Mpro represents as a drug target for the drug discovery. Herein, we have applied bioinformatics approach for screening of chemical compounds from Indian spices as potent inhibitors of SARS-CoV-2 main protease (PDBID: 6Y84). The structure files of Indian spices chemical compounds were taken from PubChem database or Zinc database and screened by molecular docking, by using AutoDock-4.2, MGLTools-1.5.6, Raccoon virtual screening tools. Top 04 hits based on their highest binding affinity were analyzed. Carnosol exhibited highest binding affinity -8.2 Kcal/mol and strong and stable interactions with the amino acid residues present on the active site of SARS-CoV-2 Mpro. Arjunglucoside-I (-7.88 Kcal/mol) and Rosmanol (-7.99 Kcal/mol) also showed a strong and stable binding affinity with favourable ADME properties. These compounds on MD simulations for 50ns shows strong hydrogen-bonding interactions with the protein active site and remains stable inside the active site. Our virtual screening results suggest that these small chemical molecules can be used as potential inhibitors against SARS-CoV-2 Mpro and may have an anti-viral effect on nCoV. However, further validation and investigation of these inhibitors against SARS-CoV-2 main protease are needed to claim their candidacy for clinical trials.","J Biomol Struct Dyn","Umesh","Kundu, Debanjan","Selvaraj, Chandrabose","Singh, Sanjeev Kumar","Dubey, Vikash Kumar","32362243"],"abstract":["The 2019-novel coronavirus (nCoV) has caused a global health crisis by causing coronavirus disease-19 (COVID-19) pandemic in the human population. The unavailability of specific vaccines and anti-viral drug for nCoV, science demands sincere efforts in the field of drug design and discovery for COVID-19. The novel coronavirus main protease (SARS-CoV-2 Mpro) play a crucial role during the disease propagation, and hence SARS-CoV-2 Mpro represents as a drug target for the drug discovery. Herein, we have applied bioinformatics approach for screening of chemical compounds from Indian spices as potent inhibitors of SARS-CoV-2 main protease (PDBID: 6Y84). The structure files of Indian spices chemical compounds were taken from PubChem database or Zinc database and screened by molecular docking, by using AutoDock-4.2, MGLTools-1.5.6, Raccoon virtual screening tools. Top 04 hits based on their highest binding affinity were analyzed. Carnosol exhibited highest binding affinity -8.2 Kcal/mol and strong and stable interactions with the amino acid residues present on the active site of SARS-CoV-2 Mpro. Arjunglucoside-I (-7.88 Kcal/mol) and Rosmanol (-7.99 Kcal/mol) also showed a strong and stable binding affinity with favourable ADME properties. These compounds on MD simulations for 50ns shows strong hydrogen-bonding interactions with the protein active site and remains stable inside the active site. Our virtual screening results suggest that these small chemical molecules can be used as potential inhibitors against SARS-CoV-2 Mpro and may have an anti-viral effect on nCoV. However, further validation and investigation of these inhibitors against SARS-CoV-2 main protease are needed to claim their candidacy for clinical trials."],"journal":"J Biomol Struct Dyn","authors":["Umesh","Kundu, Debanjan","Selvaraj, Chandrabose","Singh, Sanjeev Kumar","Dubey, Vikash Kumar"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362243","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/07391102.2020.1763202","keywords":["adme","bioinformatics","corona virus disease-2019 (covid-19","molecular docking","novel coronavirus (ncov)","novel coronavirus main protease (sars-cov-2 mpro)"],"locations":["Indian","Indian","Raccoon","Indian"],"countries":["India"],"countries_codes":["IND|India"],"e_drugs":["sericoside","carnosol","rosmanol"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495987482624,"score":334.9341},{"pmid":32388476,"title":"Is copper beneficial for COVID-19 patients?","text":["Is copper beneficial for COVID-19 patients?","Copper (Cu) is an essential micronutrient for both pathogens and the hosts during viral infection. Cu is involved in the functions of critical immune cells such as T helper cells, B cells, neutrophils natural killer (NK) cells, and macrophages. These blood cells are involved in the killing of infectious microbes, in cell-mediated immunity and the production of specific antibodies against the pathogens. Cu-deficient humans show an exceptional susceptibility to infections due to the decreased number and function of these blood cells. Besides, Cu can kill several infectious viruses such as bronchitis virus, poliovirus, human immunodeficiency virus type 1(HIV-1), other enveloped or nonenveloped, single- or double-stranded DNA and RNA viruses. Moreover, Cu has the potent capacity of contact killing of several viruses, including SARS-CoV-2. Since the current outbreak of the COVID-19 continues to develop, and there is no vaccine or drugs are currently available, the critical option is now to make the immune system competent to fight against the SARS-CoV-2. Based on available data, we hypothesize that enrichment of plasma copper levels will boost both the innate and adaptive immunity in people. Moreover, owing to its potent antiviral activities, Cu may also act as a preventive and therapeutic regime against COVID-19.","Med Hypotheses","Raha, Syamal","Mallick, Rahul","Basak, Sanjay","Duttaroy, Asim K","32388476"],"abstract":["Copper (Cu) is an essential micronutrient for both pathogens and the hosts during viral infection. Cu is involved in the functions of critical immune cells such as T helper cells, B cells, neutrophils natural killer (NK) cells, and macrophages. These blood cells are involved in the killing of infectious microbes, in cell-mediated immunity and the production of specific antibodies against the pathogens. Cu-deficient humans show an exceptional susceptibility to infections due to the decreased number and function of these blood cells. Besides, Cu can kill several infectious viruses such as bronchitis virus, poliovirus, human immunodeficiency virus type 1(HIV-1), other enveloped or nonenveloped, single- or double-stranded DNA and RNA viruses. Moreover, Cu has the potent capacity of contact killing of several viruses, including SARS-CoV-2. Since the current outbreak of the COVID-19 continues to develop, and there is no vaccine or drugs are currently available, the critical option is now to make the immune system competent to fight against the SARS-CoV-2. Based on available data, we hypothesize that enrichment of plasma copper levels will boost both the innate and adaptive immunity in people. Moreover, owing to its potent antiviral activities, Cu may also act as a preventive and therapeutic regime against COVID-19."],"journal":"Med Hypotheses","authors":["Raha, Syamal","Mallick, Rahul","Basak, Sanjay","Duttaroy, Asim K"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32388476","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.mehy.2020.109814","keywords":["blood cells","covid-19","contact killing","copper","coronavirus","cu-deficiency","cuonps","cupric chloride","immunity","ros","sars-cov-2","th1/th2 cells","viral infection"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666428892667183104,"score":131.3958},{"pmid":32237901,"pmcid":"PMC7157951","title":"Immune-epidemiological parameters of the novel coronavirus - a perspective.","text":["Immune-epidemiological parameters of the novel coronavirus - a perspective.","Introduction: At the end of 2019, Wuhan, a city in China with a population of about 11 million, witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has spread to more 199 countries and territories worldwide. The 2019 novel coronavirus, 2019-nCoV, is known as the probable causative agent of the illness.Areas covered: Here, the epidemiological dynamics of the coronavirus disease 2019 (COVID-19) that stand in close relation to distinct immunogenetic characters of the pathogen are discussed, to understand the ability and inability of the immune system in combatting COVID-19.Expert opinion: The elderly population is at increased risk of developing and dying from COVID-19. Comorbidity is present in more than 30% of cases with COVID-19. Except for less than 1% of the total, a chronic condition has been found in all cases that died from COVID-19. Men are more than 1.5 times more likely to die from COVID-19. Evidence links aging to cytokine dysregulation and T-cell repertoire reduction, male population to relatively reduced anti-viral immunity, and COVID-19-related comorbidities to hyper inflammation. The transmission of COVID-19 is influenced by the host-related factors that are known to be associated with immune dysregulation.","Expert Rev Clin Immunol","Saghazadeh, Amene","Rezaei, Nima","32237901"],"abstract":["Introduction: At the end of 2019, Wuhan, a city in China with a population of about 11 million, witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has spread to more 199 countries and territories worldwide. The 2019 novel coronavirus, 2019-nCoV, is known as the probable causative agent of the illness.Areas covered: Here, the epidemiological dynamics of the coronavirus disease 2019 (COVID-19) that stand in close relation to distinct immunogenetic characters of the pathogen are discussed, to understand the ability and inability of the immune system in combatting COVID-19.Expert opinion: The elderly population is at increased risk of developing and dying from COVID-19. Comorbidity is present in more than 30% of cases with COVID-19. Except for less than 1% of the total, a chronic condition has been found in all cases that died from COVID-19. Men are more than 1.5 times more likely to die from COVID-19. Evidence links aging to cytokine dysregulation and T-cell repertoire reduction, male population to relatively reduced anti-viral immunity, and COVID-19-related comorbidities to hyper inflammation. The transmission of COVID-19 is influenced by the host-related factors that are known to be associated with immune dysregulation."],"journal":"Expert Rev Clin Immunol","authors":["Saghazadeh, Amene","Rezaei, Nima"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32237901","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1080/1744666X.2020.1750954","keywords":["2019-ncov","covid-19","novel coronavirus","sars-cov2","immune-epidemiology"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1666138490284277760,"score":127.603546},{"pmid":32313754,"pmcid":"PMC7164711","title":"An Epidemiological Study on COVID-19: A Rapidly Spreading Disease.","text":["An Epidemiological Study on COVID-19: A Rapidly Spreading Disease.","Background The outbreak of the novel coronavirus disease in 2019 (COVID-19) caused a major public health crisis worldwide and challenged healthcare systems across the six continents. The high infectivity of the disease led many governments to adopt strict regulations and measures with the aim of containing its spread. The purpose of this study is to assess the incidence, severity, and territorial expansion of COVID-19. Methods Data from the World Health Organization was screened, and COVID-19 situation reports were extracted from January 21 up till March 14 (inclusive). Our data included the total number of cases, total number of new cases, total number of cured cases, and total number of related deaths. Percentage change of cases over the days of our study were calculated using the Joinpoint regression, with a significance level set at greater than 0.05. Results The total number of COVID-19 cases reached 156,622, with 5,845 subsequent deaths. China, Italy, and Iran have the highest number of cases worldwide. During the first 22 days, the incidence rate of COVID-19 increased significantly to reach 1.81 cases per million persons (p<0.001). That was followed by a significant decrease over the next 11 days (p<0.001) to reach 0.071 cases per million persons. A steady rise then followed, which saw a significant increase in incidence rate to 1.429 cases per million persons (p<0.001). Percentages of death and cured cases varied across the different countries; nevertheless, death percentages have generally been decreasing since the start of the crisis. Conclusion Adopting precautionary regulations such as social isolation, increasing sanitation, and employing strict quarantine measures have proved to be beneficial in containing the virus. Further research needs to be conducted to help discover therapeutic modalities and improve outcomes.","Cureus","Khachfe, Hussein H","Chahrour, Mohamad","Sammouri, Julie","Salhab, Hamza","Makki, Bassel Eldeen","Fares, Mohamad","32313754"],"abstract":["Background The outbreak of the novel coronavirus disease in 2019 (COVID-19) caused a major public health crisis worldwide and challenged healthcare systems across the six continents. The high infectivity of the disease led many governments to adopt strict regulations and measures with the aim of containing its spread. The purpose of this study is to assess the incidence, severity, and territorial expansion of COVID-19. Methods Data from the World Health Organization was screened, and COVID-19 situation reports were extracted from January 21 up till March 14 (inclusive). Our data included the total number of cases, total number of new cases, total number of cured cases, and total number of related deaths. Percentage change of cases over the days of our study were calculated using the Joinpoint regression, with a significance level set at greater than 0.05. Results The total number of COVID-19 cases reached 156,622, with 5,845 subsequent deaths. China, Italy, and Iran have the highest number of cases worldwide. During the first 22 days, the incidence rate of COVID-19 increased significantly to reach 1.81 cases per million persons (p<0.001). That was followed by a significant decrease over the next 11 days (p<0.001) to reach 0.071 cases per million persons. A steady rise then followed, which saw a significant increase in incidence rate to 1.429 cases per million persons (p<0.001). Percentages of death and cured cases varied across the different countries; nevertheless, death percentages have generally been decreasing since the start of the crisis. Conclusion Adopting precautionary regulations such as social isolation, increasing sanitation, and employing strict quarantine measures have proved to be beneficial in containing the virus. Further research needs to be conducted to help discover therapeutic modalities and improve outcomes."],"journal":"Cureus","authors":["Khachfe, Hussein H","Chahrour, Mohamad","Sammouri, Julie","Salhab, Hamza","Makki, Bassel Eldeen","Fares, Mohamad"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313754","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.7759/cureus.7313","keywords":["coronavirus","covid-19","epidemiology","infectious disease","novel coronavirus"],"locations":["China","Italy","Iran"],"countries":["Italy","China","Iran, Islamic Republic of"],"countries_codes":["ITA|Italy","CHN|China","IRN|Iran, Islamic Republic of"],"topics":["Prevention"],"weight":1,"_version_":1666138493521231876,"score":125.75227},{"pmid":32480226,"title":"Effects of host genetic variations on response to, susceptibility and severity of respiratory infections.","text":["Effects of host genetic variations on response to, susceptibility and severity of respiratory infections.","The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global crisis, necessitating the identification of genetic factors that modulate the risk of disorder or its severity. The current data about the role of genetic risk factors in determination of rate of SARS-CoV-2 infection in each ethnic group and the severity of disorder is limited. Moreover, several confounding parameters such as the number of tests performed in each country, the structure of the population especially the age distribution, the presence of risk factors for respiratory disorders such as smoking and other environmental factors might be involved in the variability in disease course or prevalence of infection among different ethnic groups. However, assessment of the role of genetic variants in determination of the course of other respiratory infections might help in recognition of possible candidate for further analysis in patients affected with SARS-CoV-2. In the current review, we summarize the data showing the association between genomic variants and risk of acute respiratory distress syndrome, respiratory infections or severity of these conditions with an especial focus on the SARS-CoV-2.","Biomed Pharmacother","Ghafouri-Fard, Soudeh","Noroozi, Rezvan","Vafaee, Reza","Branicki, Wojciech","Pospiech, Ewelina","Pyrc, Krzysztof","Labaj, Pawel P","Omrani, Mir Davood","Taheri, Mohammad","Sanak, Marek","32480226"],"abstract":["The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global crisis, necessitating the identification of genetic factors that modulate the risk of disorder or its severity. The current data about the role of genetic risk factors in determination of rate of SARS-CoV-2 infection in each ethnic group and the severity of disorder is limited. Moreover, several confounding parameters such as the number of tests performed in each country, the structure of the population especially the age distribution, the presence of risk factors for respiratory disorders such as smoking and other environmental factors might be involved in the variability in disease course or prevalence of infection among different ethnic groups. However, assessment of the role of genetic variants in determination of the course of other respiratory infections might help in recognition of possible candidate for further analysis in patients affected with SARS-CoV-2. In the current review, we summarize the data showing the association between genomic variants and risk of acute respiratory distress syndrome, respiratory infections or severity of these conditions with an especial focus on the SARS-CoV-2."],"journal":"Biomed Pharmacother","authors":["Ghafouri-Fard, Soudeh","Noroozi, Rezvan","Vafaee, Reza","Branicki, Wojciech","Pospiech, Ewelina","Pyrc, Krzysztof","Labaj, Pawel P","Omrani, Mir Davood","Taheri, Mohammad","Sanak, Marek"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32480226","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.biopha.2020.110296","keywords":["ace","covid-19","sars-cov-2","genetic","respiratory tract infection","single nucleotide polymorphism"],"topics":["Mechanism"],"weight":1,"_version_":1668437835055628288,"score":122.516815}]}